Literature DB >> 12707724

Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane.

A Deviren1, N Yalman, S Hacihanefioglu.   

Abstract

Fanconi anemia (FA) is an autosomal recessive inherited disorder which is associated with a variety of congenital anomalies. These include morphometric abnormalities involving mainly the head and face, skeletal malformations particularly of the radial ray, growth retardation, abnormal skin pigmentation, deafness, and renal, ocular, genital, and cardiac defects. The cardinal clinical feature is a severe progressive pancytopenia. The overall aim of our study was to compare two different alkylating agents that would permit rapid and unequivocal detection of FA. A total of 271 patients underwent nitrogen mustard (NTM) and diepoxybutane (DEB) tests in our laboratory; baseline chromosomal breakage was studied for all of them. After the results of the chromosomal breakage studies, 72 patients were diagnosed as affected and 136 patients as unaffected by FA. We also studied 63 family members of FA patients. According to our study, NTM seems more specific to identify chromosomal breakages in FA parents than DEB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707724     DOI: 10.1007/s00277-003-0614-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  3 in total

1.  Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency.

Authors:  Laure Gineau; Céline Cognet; Nihan Kara; Francis Peter Lach; Jean Dunne; Uma Veturi; Capucine Picard; Céline Trouillet; Céline Eidenschenk; Said Aoufouchi; Alexandre Alcaïs; Owen Smith; Frédéric Geissmann; Conleth Feighery; Laurent Abel; Agata Smogorzewska; Bruce Stillman; Eric Vivier; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

2.  Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes.

Authors:  John H Fargo; Andrzej Rochowski; Neelam Giri; Sharon A Savage; Susan B Olson; Blanche P Alter
Journal:  Cytogenet Genome Res       Date:  2014-09-11       Impact factor: 1.636

3.  Management of oral leukoplakia in patients with Fanconi anemia.

Authors:  Roberto Pippi; Cira Di Gioia; Ursula La Rocca; Amelia Bellisario; Anna Paola Iori
Journal:  J Oral Maxillofac Pathol       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.